INVO Fertility, Inc. Reports Change in Certifying Accountant
Ticker: IVF · Form: 8-K · Filed: Sep 5, 2025 · CIK: 1417926
Sentiment: neutral
Topics: auditor-change, administrative
Related Tickers: IVOF
TL;DR
INVO Fertility (IVOF) switched accountants, filing an 8-K on 9/3/25.
AI Summary
INVO Fertility, Inc. filed an 8-K on September 3, 2025, reporting changes in its certifying accountant. The company, formerly known as NAYA Biosciences, Inc. and INVO Bioscience, Inc., is incorporated in Nevada and headquartered in Sarasota, Florida.
Why It Matters
A change in a company's auditor can signal potential concerns about financial reporting or internal controls, warranting investor attention.
Risk Assessment
Risk Level: low — This filing solely reports a change in the company's independent auditor, which is a routine administrative event.
Key Players & Entities
- INVO Fertility, Inc. (company) — Registrant
- NAYA Biosciences, Inc. (company) — Former Company Name
- INVO Bioscience, Inc. (company) — Former Company Name
- September 3, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a change in the registrant's certifying accountant.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on September 3, 2025.
What is the current name of the registrant?
The current name of the registrant is INVO Fertility, Inc.
What are some of the former names of INVO Fertility, Inc.?
Some of the former names of INVO Fertility, Inc. include NAYA Biosciences, Inc. and INVO Bioscience, Inc.
In which state is INVO Fertility, Inc. incorporated?
INVO Fertility, Inc. is incorporated in Nevada.
Filing Stats: 900 words · 4 min read · ~3 pages · Grade level 14.1 · Accepted 2025-09-05 17:29:33
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value IVF The Nasdaq Stock Mark
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex16-1.htm (EX-16.1) — 5KB
- ex16-1_001.jpg (GRAPHIC) — 6KB
- 0001641172-25-026757.txt ( ) — 218KB
- ivf-20250903.xsd (EX-101.SCH) — 3KB
- ivf-20250903_lab.xml (EX-101.LAB) — 33KB
- ivf-20250903_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 5, 2025 INVO FERTILITY, INC. /s/ Steven Shum Steven Shum Chief Executive Officer